Ontology highlight
ABSTRACT: Purpose
The increasing diabetes prevalence and advent of new treatments for its major visual-threatening complications (diabetic macular edema [DME] and proliferative diabetic retinopathy [PDR]), which require frequent life-long follow-up, have increased hospital demands markedly. Subsequent delays in patient's evaluation and treatment are causing sight loss. Strategies to increase capacity are needed urgently. The retinopathy (EMERALD) study tested diagnostic accuracy, acceptability, and costs of a new health care pathway for people with previously treated DME or PDR.Design
Prospective, multicenter, case-referent, cross-sectional, diagnostic accuracy study undertaken in 13 hospitals in the United Kingdom.Participants
Adults with type 1 or 2 diabetes previously succ
SUBMITTER: Lois N
PROVIDER: S-EPMC7980088 | biostudies-literature | 2021 Apr
REPOSITORIES: biostudies-literature